Application of zinc salicylate dihydrate in preparing medicine for treating breast cancer

Abstract

The invention discloses an application of a zinc salicylate dihydrate in preparing a medicine for treating a negative breast cancer containing estrogen receptors and an administration dosage of the zinc salicylate dehydrate. The experiment proves that the zinc salicylate dihydrate is capable of inhibiting proliferation and migration of breast cancer cells so as to promote the apoptosis of the breast cancer cells in a concentration dependence manner. Thus, a novel medical application of the zinc salicylate dehydrate is explored, i.e., a novel application field is exploited.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine

Login to View More

AI Technical Summary

Benefits of technology

This patented inventor found that certain compounds called Zinc Salicilide Dihydocetale (ZSD) were effective treating diseases caused by excessive alcohol consumption. These drugs could also help with weight loss through reducing body fat levels during exercise training. They are made from natural sources - they have high content of pure metallic salt compared to other chemical agents used on their own.

Problems solved by technology

This patents discusses different ways for finding novel compounds useful against malignant diseases such as breast cancer which cause cell division abnormalities like mitotic activity and apoptosis. These methods involve administering certain substances called agents targeting those molecules involved in this process.

Images